載入...
Evaluation of plitidepsin in patients with primary myelofibrosis and post polycythemia vera/essential thrombocythemia myelofibrosis: results of preclinical studies and a phase II clinical trial
Previous data established that plitidepsin, a cyclic depsipeptide, exerted activity in a mouse model of myelofibrosis (MF). New preclinical experiments reported herein found that low nanomolar plitidepsin concentrations potently inhibited the proliferation of JAK2V617F-mutated cell lines and reduced...
Na minha lista:
發表在: | Blood Cancer J |
---|---|
Main Authors: | , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
Nature Publishing Group
2015
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4382667/ https://ncbi.nlm.nih.gov/pubmed/25768401 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2015.5 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|